We clarified that PiHL upregulation is an independent predictor for poor prognosis of CRC patients in two independent cohorts, and PiHL was able to promote proliferation and inhibit apoptosis of CRC in vitro and in vivo9. The gene discussed is PCAT1; the disease is colorectal carcinoma.